Trk A antagonist (Zebra Biologics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTrk A antagonist (Zebra Biologics)
Drug Alias Nametropomysin receptor kinase A antagonist (Zebra Biologics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsPeripheral Nervous System DiseasesCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZebra Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZebra Biologics Inc
Active IndicationsN/A
Inactive IndicationsPeripheral Nervous System DiseasesCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A